According to our (Global Info Research) latest study, the global Neurovascular Devices & Interventional Neurology market size was valued at US$ 3601 million in 2024 and is forecast to a readjusted size of USD 4931 million by 2031 with a CAGR of 4.9% during review period.
Neurovascular devices refer to a range of medical devices used for the diagnosis, treatment, and management of diseases related to the nervous system, particularly those involving the brain, spinal cord, and their blood vessels. These devices play a vital role in the diagnosis and treatment of conditions such as stroke, cerebral aneurysms, cerebrovascular diseases, traumatic brain injuries, and other neurovascular disorders. Neurovascular devices include thrombectomy devices, intracranial stents, embolization devices, and flow diversion devices, which are widely used in neurointerventional procedures. Interventional neurology refers to a medical specialty that utilizes minimally invasive techniques to treat neurological diseases, such as catheter-based approaches, percutaneous punctures, or endovascular interventions. These procedures directly target the neurological system and blood vessels, repairing or modifying damaged areas. In particular, interventional neurology has achieved significant success in the treatment of stroke, aneurysms, and cerebrovascular stenosis, offering a less invasive alternative to traditional surgery, resulting in shorter recovery times and reduced treatment risks.
Market Development Opportunities and Key Drivers: The growth of the neurovascular devices and interventional neurology market is driven by several key factors:
1. Aging Population: As the global population ages, the incidence of stroke, aneurysms, and other age-related neurovascular diseases continues to rise. This leads to an increased demand for related treatment devices.
2. Technological Advancements: Continuous advancements in medical imaging and minimally invasive surgery techniques have significantly improved the success and safety rates of neurointerventional procedures, driving the adoption of neurovascular devices.
3. Widespread Early Diagnosis and Treatment: With improvements in diagnostic tools and growing awareness of cerebrovascular diseases, more patients are receiving treatment at earlier stages, thereby increasing the demand for neurovascular devices.
4. Patient Preference for Minimally Invasive Treatment: Compared to traditional open surgeries, minimally invasive procedures are preferred by patients due to smaller incisions, quicker recovery times, and reduced risks, which has led to a rise in neurointerventional treatments.
Market Risks:
1. High Treatment Costs: Neurovascular devices and interventional neurology equipment are often expensive, which may limit their adoption in certain countries and regions.
2. Technology Dependence: These devices rely heavily on advanced technologies, such as medical imaging and catheter-based techniques, which can increase the technical demands on healthcare professionals and the risk of complications.
3. Regulatory and Certification Issues: Different regions have varying regulatory standards and approval processes for medical devices, which may present challenges in terms of market entry and device promotion.
Market Concentration: The global neurovascular device market is dominated by several large companies, including Medtronic, Abbott, and Stryker. These companies possess strong competitive advantages in terms of technology development, market penetration, and product supply chains. However, many small and medium-sized enterprises are emerging in the market, driving innovation and product diversification.
Downstream Demand Trends:
1. Increasing Demand for Stroke Treatment: As the incidence of stroke rises globally, there is a growing demand for thrombectomy devices and stents.
2. Rising Demand for Aneurysm and Stenosis Treatment: The treatment of cerebral aneurysms and vascular stenosis is increasing, leading to a greater need for embolization devices and stents.
3. Widespread Adoption of Minimally Invasive Surgeries: The preference for minimally invasive procedures is boosting the adoption of neurointerventional treatments, further driving the demand for neurovascular devices.
Latest Technologies:
1. Thrombectomy Technology: Thrombectomy devices enable rapid and effective treatment for acute ischemic stroke patients, significantly improving survival rates.
2. Flow Diversion Devices: Used for treating cerebral aneurysms, these devices alter the blood flow path, reducing the risk of aneurysm rupture.
3. 3D Imaging Technology: Coupled with 3D imaging, doctors can precisely locate the site of the lesion, improving the success rate of surgeries.
These technological innovations and market trends continue to shape the neurovascular devices and interventional neurology market, making it one of the most promising sectors in the medical device industry.
This report is a detailed and comprehensive analysis for global Neurovascular Devices & Interventional Neurology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neurovascular Devices & Interventional Neurology market size and forecasts, in consumption value ($ Million), 2020-2031
Global Neurovascular Devices & Interventional Neurology market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Neurovascular Devices & Interventional Neurology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Neurovascular Devices & Interventional Neurology market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurovascular Devices & Interventional Neurology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurovascular Devices & Interventional Neurology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo Neuro, Penumbra, Inc. (Neuro), Shanghai MicroPort Medical (Group) Co.,Ltd., Abbott Vascular, Medical Murray, Boston Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Neurovascular Devices & Interventional Neurology market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Thrombectomy Devices
Intracranial Stents
Embolization Devices
Flow Diversion Devices
Others
Market segment by Application
Hospitals
Clinics
Ambulatory Surgical Units
Market segment by players, this report covers
Stryker Corporation
Johnson & Johnson
Medtronic
Terumo Neuro
Penumbra, Inc. (Neuro)
Shanghai MicroPort Medical (Group) Co.,Ltd.
Abbott Vascular
Medical Murray
Boston Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neurovascular Devices & Interventional Neurology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurovascular Devices & Interventional Neurology, with revenue, gross margin, and global market share of Neurovascular Devices & Interventional Neurology from 2020 to 2025.
Chapter 3, the Neurovascular Devices & Interventional Neurology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Neurovascular Devices & Interventional Neurology market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurovascular Devices & Interventional Neurology.
Chapter 13, to describe Neurovascular Devices & Interventional Neurology research findings and conclusion.
Summary:
Get latest Market Research Reports on Neurovascular Devices & Interventional Neurology. Industry analysis & Market Report on Neurovascular Devices & Interventional Neurology is a syndicated market report, published as Global Neurovascular Devices & Interventional Neurology Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Neurovascular Devices & Interventional Neurology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.